quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:06·798d
SECFiling
Theseus Pharmaceuticals Inc. logo

SEC Form EFFECT filed by Theseus Pharmaceuticals Inc.

THRX· Theseus Pharmaceuticals Inc.
Health Care
Original source

Companies

  • THRX
    Theseus Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Jul 14UpdateNeedham-
  • Mar 16UpdateStifel$24.00
  • Dec 14UpdateNeedham$22.00
  • Jun 30UpdateH.C. Wainwright$22.00
  • Nov 1UpdateCantor Fitzgerald$25.00
  • Nov 1UpdateWedbush$24.00

Related

  • SEC787d
    SEC Form 15-12G filed by Theseus Pharmaceuticals Inc.
  • 13D/G797d
    SEC Form SC 13D/A filed by Theseus Pharmaceuticals Inc. (Amendment)
  • INSIDER799d
    SEC Form 4 filed by Yi Kathy
  • INSIDER799d
    SEC Form 4 filed by Stein Steven H
  • INSIDER799d
    SEC Form 4 filed by Orbimed Advisors Llc
  • INSIDER799d
    Hayden Donald J Jr closing all direct ownership in the company (SEC Form 4)
  • INSIDER799d
    Dukes Iain D. closing all direct ownership in the company (SEC Form 4)
  • INSIDER799d
    SEC Form 4 filed by Gordon Carl L
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022